These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14967079)

  • 1. Systematic review of intratympanic gentamicin in Meniere's disease.
    Diamond C; O'Connell DA; Hornig JD; Liu R
    J Otolaryngol; 2003 Dec; 32(6):351-61. PubMed ID: 14967079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin for Ménière's disease or syndrome.
    Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008234. PubMed ID: 21412917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic gentamicin for Ménière's disease.
    Webster KE; Galbraith K; Lee A; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015246. PubMed ID: 36847592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D; Patrikakos G
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B; Ozgirgin N; Ozlüoğlu LN
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic gentamicin compared with placebo for Ménière's disease.
    de Amesti F; Santander MJ; Winter M
    Medwave; 2022 Mar; 22(2):e8696. PubMed ID: 35323825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results.
    Driscoll CL; Kasperbauer JL; Facer GW; Harner SG; Beatty CW
    Laryngoscope; 1997 Jan; 107(1):83-9. PubMed ID: 9001270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic gentamicin for Menière's disease: a meta-analysis.
    Cohen-Kerem R; Kisilevsky V; Einarson TR; Kozer E; Koren G; Rutka JA
    Laryngoscope; 2004 Dec; 114(12):2085-91. PubMed ID: 15564826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report.
    Rauch SD; Oas JG
    Laryngoscope; 1997 Jan; 107(1):49-55. PubMed ID: 9001265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic steroids for Ménière's disease or syndrome.
    Phillips JS; Westerberg B
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008514. PubMed ID: 21735432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing].
    Wang XY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):942-944. PubMed ID: 29771059
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
    Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
    Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease.
    Harcourt JP; Lambert A; Wong PY; Patel M; Agarwal K; Golding JF; Bronstein AM
    Otol Neurotol; 2019 Apr; 40(4):491-496. PubMed ID: 30870364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis.
    Chia SH; Gamst AC; Anderson JP; Harris JP
    Otol Neurotol; 2004 Jul; 25(4):544-52. PubMed ID: 15241234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.